2025 RNDS | Open Q&A with SRNA James T. Lubin Fellows @wearesrna
2025 RNDS | Open Q&A with SRNA James T. Lubin Fellows  @wearesrna
Uploaded December 2025 | Updated September 2026, 1 week ago
During this panel at the 2025 Virtual RNDS, doctors answered several audience-submitted questions, including the following:
. Do people who have been diagnosed for a long time with TM need to know their AQP4 and MOG status?
. I haven’t had a flare in a year—should I continue monitoring for signs of a relapse, or how do I know I’m in the clear?
. Are there any causes or triggers to attacks, and any way to prevent them beyond medication?
. Are there any supplements I should be taking?
. What are your recommendations for vaccines?
. I was diagnosed with TM, then NMO, then MOG—but my symptoms are closest to NMO. How should I proceed?
. Does GLP-1s interact with rare neuroimmune disorders/rare neuroimmune disorder treatments?
Can Rituxan cause GI issues?
2025 RNDS | Open Q&A with SRNA James T. Lubin Fellows2025 RNDS | Welcome RemarksAsk the Expert 1404. MOGcast | The State of MOGAD Science1309. Parenting is Hard | Part 51301. Vaccines and Immunosuppression2023 RNDS | Urological management in rare neuroimmune disorders2024 RNDS | Community Perspectives Panel: Navigating Work, Travel, Setting Boundaries, and More2025 RNDS | Rehabilitation and recovery in rare neuroimmune disordersThe Power Of Community: Teaser2025 RNDS | 2025 Update on the Q-cells Study1112. Social Determinants of Health in Rare Neuroimmune Disorders2024 RNDS | A Conversation: How Do I Identify a Relapse?
SRNA |

2025 RNDS | Open Q&A with SRNA James T. Lubin Fellows

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER